Food and Drug Administration advisers will meet Wednesday to hash out what the future of COVID-19 boosters will look like in the United States.
It's a question that looms large: Just a week ago, the FDA and the Centers for Disease Control and Prevention signed off on a second booster dose for people ages 50 and up, four months after their first booster.
WATCH ANYTIME FOR FREE
 |
Stream NBC10 Boston news for free, 24/7, wherever you are. |
But fewer than half of eligible adults have even received that first booster shot, and some health experts question whether getting additional doses of the vaccines every few months to protect against mild illness is a practical public health strategy.
The all-day meeting Wednesday of the agency’s Vaccines and Related Biological Products Advisory Committee will try to answer these questions, or at least develop a framework for a long-term booster strategy, according to briefing documents released by the FDA before the meeting.
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
